JPRN-jRCT2031210012已完成1 期
A pharmacological study of M1151C2 to assess effect on local safety
ishiura Tomoyuki0 个研究点目标入组 30 人开始时间: 2021年4月6日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Confirmed diagnosis of atopic dermatitis
排除标准
- •Patients with a history of, or currently with any of the following diseases:
- •1) malignact tumor
- •2) Serious allergy (shock, anaphylactoid symptoms)
- •3) Allergy to tacrolimus
- •4) Cutaneous hypersensitivity to topical drugs (e.g., allergic contact dermatitis)
- •Patients with any of the following diseases:
- •1) Diseases considered inappropriate for study participation, such as serious cardiac, hepatic, renal, pulmonary, or hematologic diseases
- •2) Severe renal dysfunction, severe hyperkalemia or symptoms caused by them
- •3) ulcer or erosion clearly forming a plaque at the application site of the investigational drug
- •4) Diseases with ichthyosis-like erythroderma (Netherton syndrome, etc.)
- •5) Skin infections at the application site of the investigational
研究者
相似试验
已完成
2 期
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis PatientsPlaque PsoriasisNCT01301157Maruho Co., Ltd.294
已完成
2 期
Phase IIb Study of Evobrutinib in Subjects With Rheumatoid ArthritisRheumatoid ArthritisNCT03233230EMD Serono Research & Development Institute, Inc.390
已完成
1 期
A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive CancerHER-2 Gene AmplificationNCT01304784Merrimack Pharmaceuticals100
尚未招募
3 期
A clinical trial to study the effect of collagen supplement on chronic periodontitis patient and on nitrtic oxide level in the saliva.CTRI/2024/05/068104Yogita Kshirsagar
已完成
2 期
Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 DiabetesType 2 DiabetesNCT02057172Hanmi Pharmaceutical Company Limited254